Keyphrases
Type I Diabetes
87%
Type 1 Diabetes Mellitus (T1DM)
87%
Hypoglycemia Unawareness
36%
Lipids
28%
Cardiovascular Disease
22%
Metabolomics
19%
Cardiovascular Risk Management
19%
Low-density Lipoprotein Cholesterol (LDL-C)
18%
Between-person
18%
Netherlands
18%
Clinical Transcriptomics
16%
Diabetic Management
16%
Type 1 Diabetes Management
16%
Blood Pressure Measurement
16%
Cohort Profile
16%
Prospective Cohort Study
16%
Clinical Phenotyping
16%
Metabotype
16%
Antihypertensive Medication
16%
Target Attainment
12%
Blood Pressure
11%
Blood Pressure Target
10%
Dutch
9%
Hemoglobin A1c (HbA1c)
9%
Blood Pressure Management
8%
Vascular Complications
8%
Meal Tolerance Test
8%
Insulin Pump
7%
Guideline Recommendations
7%
Phosphatidylcholine
6%
Continuous Glucose Monitoring
5%
1-year Follow-up
5%
C-peptide Secretion
5%
Diabetes Duration
5%
C-peptide
5%
Biochemistry, Genetics and Molecular Biology
Awareness
79%
Metabolomics
41%
Blood Pressure
33%
Phenotype
33%
Prospective Cohort Study
33%
C-Peptide
33%
Low-Density Lipoprotein
25%
Metabolite
22%
Lipid
22%
Genome-Wide Association Study
20%
Genetics
20%
Single Nucleotide Polymorphism
18%
Population
16%
Cross Sectional Study
16%
Agouti-Related Protein
16%
Transcriptomics
16%
Chemokine
16%
Secretion (Process)
16%
Sphingomyelin
10%
Glycated Hemoglobin
9%
Agouti-Related Peptide
9%
Egg Lecithin
8%
Cholesterol Blood Level
8%
Autoimmunity
8%
Gene Linkage
8%
Gene Expression Data
8%
Cohort Study
8%
Urine Sampling
8%
Cell Function
8%
MicroRNA
8%
Protein Expression
5%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Blood Pressure
39%
Biological Marker
35%
Diabetes
34%
Prospective Cohort Study
33%
Phenotype
33%
Hemoglobin A1c
27%
Awareness
23%
Hypoglycemia
23%
Drug Therapy
21%
C-Peptide
21%
Cardiovascular Disease
20%
Cardiovascular Risk
20%
Meal
16%
Cardiovascular System
16%
Alertness
16%
Antihypertensive Agent
14%
Low Density Lipoprotein Cholesterol
14%
Beta Cell
11%
Insulin Pump
10%
Secretion (Process)
9%
Glycemic
9%
Microvascular Complication
6%
